Comparison of risk of malignancy indices in evaluating ovarian masses in a southeast asian population

Singapore Medical Journal

Volumn 54, Issue 3, 2013, Pages 136-139

  Ong, Clara ^a   Biswas, Arijit ^a,b   Choolani, Mahesh ^a,b   Low, Jeffrey Jen Hui ^a,b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CA125; Ovarian cancer; Risk of malignancy index; Ultrasonography

Indexed keywords

CA 125 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CHILD; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; OVARY CARCINOMA; RETROSPECTIVE STUDY; RISK OF MALIGNANCY INDEX; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; CA-125 ANTIGEN; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; OVARIAN CYSTS; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; RISK; ROC CURVE; SENSITIVITY AND SPECIFICITY; SINGAPORE; YOUNG ADULT;

EID: 84875425498     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: 10.11622/smedj.2013046     Document Type: Article

References (13)

1. Trends in cancer incidence in Singapore 1968-2007. Singapore Cancer Registr y Repor t Number 7. Singapore: National Registry of Diseases Of fce, 2010.
2. Singapore Cancer Registry interim report. Trends in cancer incidence in Singapore, 2004-2008. Singapore: National Registry of Diseases Offce, 2010.
3. Junor EJ, Hole DJ, McNulty L, Mason M, Young J. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol 1999; 106:1130-1136.
4. Jacobs I, Oram D, Fair bank s J, et al. A risk of malignancy ind ex incorpo rat ing CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990; 97:922-929.
5. Tingulstad S, Hagen B, Skjeldestad FE, et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol 1996; 103:826-831.
6. Tingulstad S, Hagen B, Skjeldestad FE, et al. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol 199 9; 93:448-452.
7. Morgante G, la Marca A, Ditto A, De Leo V. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses. Br J Obstet Gynaecol 1999; 106:524-527.
8. Yamamoto Y, Yamada R, Oguri H, Maeda N, Fukaya T. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses. Eur J Obstet Gynecol Reprod Biol 2009; 144:163-167.
9. Manjunath AP, Pratapkumar, Sujatha K, Vani R. Comparison of three risk of malignancy indices in evaluation of pelvic masses. Gynecol Oncol 2001; 81:225-229.
10. Davies AP, Jacobs I, Woolas R, Fish A, Oram D. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol 1993; 100:927-931.
11. Molina R, Escudero JM, Augé JM, et al. HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases. Tumour Biol 2011; 32:1087-1095.
12. Moore RG, Jabre-Raughley M, Brown AK, et al. Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Am J Obstet Gynecol 2010; 203:228.e1-e6.
13. Andersen MR, Goff BA, Lowe KA, et al. Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer. Gynecol Oncol 2010; 116:378-383.